If you were to consider which of Rett, PDD, and AD is most unlike the others, you would pick Rett, not AD. And we have strong evidence that, for purposes of 2-73, Rett falls within its domain of efficacy.
If you don’t know that AVXL has produced absolutely glowing trial results up till now, then you never will. The advanced trials which will report within the next year have already been shown to be successful beyond most expectations. These trials will not fail!
He is going after the same thing that BIIB is targeting. Plaque. They remove them, we prevent them from even being created. THEY will be of no use once we are taken as a preventative.
Plus all of those “OTHER” effects that Blarcamesine may potentially achieve.
Warning: you may get a slight headache as a side effect.
News 
Market Data 
Discover 
AI
